Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T900607 in chemotherapy-naive unresectable hepatocellular carcinoma
NCT00054262Phase 2Completed
- Sponsor
- University Hospitals Seidman Cancer Center
- Start
- Nov 2002
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of t900607 in hepatocellular carcinoma (HCC), sponsored by University Hospitals Seidman Cancer Center. Started Nov 2002; status: completed.
02
Drugs
t900607
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00054262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054262.